Currently there is scarce information in Rwanda on patient outcomes of antiretroviral therapy (ART). With his research, John Rusine aims to provide greater insight into clinical, immunological and virological outcomes (and outcome predictors) of combined antiretroviral treatment (cART) in HIV-infected adults and children initiating or already under treatment in Rwanda. He also studies the interplay between hepatitis and HIV infection.
J. Rusine: HIV Drug Resistance and Hepatitis co-infections in HIV-infected Adults and Children Initiating Antiretroviral Therapy in Rwanda.
Prof. M.D. de Jong
Prof. J.H.H.M. van de Wijgert
Dr P.L.A. Ondoa
This event is open to the public.